汇添富创新医药混合A(006113)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-748,916,971.86 |
1,867,097,352.25 |
1,812,151,970.11 |
-1,326,351,282.18 |
| 利息合计 |
2,021,149.25 |
3,208,544.56 |
1,602,439.78 |
2,988,203.56 |
| 其中:存款利息收入 |
2,021,149.25 |
2,520,900.12 |
914,795.34 |
2,491,616.08 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
687,644.44 |
687,644.44 |
496,587.48 |
| 投资收益合计 |
459,724,421.87 |
899,335,867.12 |
144,293,966.07 |
-1,556,783,283.88 |
| 其中:股票投资收益 |
428,205,354.88 |
857,672,239.45 |
127,791,576.45 |
-1,620,468,879.71 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
381.36 |
1,126,017.61 |
1,113,721.33 |
11,150,850.65 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
31,518,685.63 |
40,537,610.06 |
15,388,668.29 |
52,534,745.18 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-1,214,258,166.75 |
922,589,083.32 |
1,640,545,048.52 |
226,803,083.87 |
| 其他收入 |
3,595,623.77 |
41,963,857.25 |
25,710,515.74 |
640,714.27 |
| 费用 |
94,906,777.67 |
141,117,799.65 |
41,597,084.92 |
74,802,713.73 |
| 管理人报酬 |
69,764,270.08 |
109,915,343.65 |
35,126,052.27 |
63,893,109.31 |
| 基金托管费 |
11,627,378.38 |
18,319,223.88 |
5,854,342.03 |
10,648,851.58 |
| 销售服务费 |
13,169,626.25 |
12,356,693.47 |
437,020.50 |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
345,502.96 |
526,520.13 |
179,651.60 |
260,752.84 |
| 利润总额 |
-843,823,749.53 |
1,725,979,552.60 |
1,770,554,885.19 |
-1,401,153,995.91 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年